ArticlePloS one2015

Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.

Erin H Breese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.